Counterpoint: PCI is no better than medical therapy for stable angina? Seeing is not believing

Article Type
Changed
Thu, 07/19/2018 - 09:33
Display Headline
Counterpoint: PCI is no better than medical therapy for stable angina? Seeing is not believing
Interpreting the COURAGE trial
Article PDF
Author and Disclosure Information

Dean J. Kereiakes, MD
Medical Director, The Christ Hospital Heart & Vascular Center and The Lindner Research Center; Chairman, Executive Committee, Ohio Heart & Vascular Center, Inc. Cincinnati; Professor of Clinical Medicine, The Ohio State University, Columbus

Address: Dean J. Kereiakes, MD, The Lindner Center for Research and Education, 2123 Auburn Avenue, Suite 424, Cincinnati, OH 45219

Dr. Kereiakes has indicated that he has received grant or research support from the Boston Scientific, Cordis Johnson & Johnson, Daiichi Sanyko, Medtronic, and Pfizer corporations; has received consulting fees from the Abbott Vascular, Boston Scientific, CoreValve, Cordis Johnson & Johnson, and Eli Lilly corporations; and is on the speaker's bureau of Eli Lilly and company.

Issue
Cleveland Clinic Journal of Medicine - 74(9)
Publications
Topics
Page Number
637-638, 640-642
Sections
Author and Disclosure Information

Dean J. Kereiakes, MD
Medical Director, The Christ Hospital Heart & Vascular Center and The Lindner Research Center; Chairman, Executive Committee, Ohio Heart & Vascular Center, Inc. Cincinnati; Professor of Clinical Medicine, The Ohio State University, Columbus

Address: Dean J. Kereiakes, MD, The Lindner Center for Research and Education, 2123 Auburn Avenue, Suite 424, Cincinnati, OH 45219

Dr. Kereiakes has indicated that he has received grant or research support from the Boston Scientific, Cordis Johnson & Johnson, Daiichi Sanyko, Medtronic, and Pfizer corporations; has received consulting fees from the Abbott Vascular, Boston Scientific, CoreValve, Cordis Johnson & Johnson, and Eli Lilly corporations; and is on the speaker's bureau of Eli Lilly and company.

Author and Disclosure Information

Dean J. Kereiakes, MD
Medical Director, The Christ Hospital Heart & Vascular Center and The Lindner Research Center; Chairman, Executive Committee, Ohio Heart & Vascular Center, Inc. Cincinnati; Professor of Clinical Medicine, The Ohio State University, Columbus

Address: Dean J. Kereiakes, MD, The Lindner Center for Research and Education, 2123 Auburn Avenue, Suite 424, Cincinnati, OH 45219

Dr. Kereiakes has indicated that he has received grant or research support from the Boston Scientific, Cordis Johnson & Johnson, Daiichi Sanyko, Medtronic, and Pfizer corporations; has received consulting fees from the Abbott Vascular, Boston Scientific, CoreValve, Cordis Johnson & Johnson, and Eli Lilly corporations; and is on the speaker's bureau of Eli Lilly and company.

Article PDF
Article PDF
Related Articles
Interpreting the COURAGE trial
Interpreting the COURAGE trial
Issue
Cleveland Clinic Journal of Medicine - 74(9)
Issue
Cleveland Clinic Journal of Medicine - 74(9)
Page Number
637-638, 640-642
Page Number
637-638, 640-642
Publications
Publications
Topics
Article Type
Display Headline
Counterpoint: PCI is no better than medical therapy for stable angina? Seeing is not believing
Display Headline
Counterpoint: PCI is no better than medical therapy for stable angina? Seeing is not believing
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media